Brytly vs Lumify: Which Redness-Relief Eye Drop Is Better?

Brytly vs Lumify at a Glance

How Do Brytly and Lumify Work?

Most everyday eye redness comes from the small conjunctival blood vessels widening in response to dryness, dust, smoke, allergies, screens or a short night. Redness-relief drops are vasoconstrictors: they act on adrenergic receptors in the vessel walls and make the vessels narrow, so less blood shows through the white of the eye.

The receptor matters. A 2020 review of U.S. OTC eye decongestants explains that older drops work through the alpha-1 receptor (tetrahydrozoline, the ingredient in Visine Original) or both alpha-1 and alpha-2 (naphazoline). Drugs with alpha-1 activity have been linked to tachyphylaxis (the drop stops working as well with repeated use) and rebound redness when you stop. Lumify’s brimonidine is a selective alpha-2 agonist, and in its trials tachyphylaxis was not observed and rebound was rarely reported. That review was written by Bausch + Lomb employees, so read it with that in mind.

Apraclonidine, Brytly’s ingredient, is a close relative of clonidine. It has been used for decades in prescription drops (Iopidine 0.5% and 1%) to lower eye pressure, at 4 to 8 times Brytly’s concentration. It acts mainly on alpha-2 receptors but keeps some alpha-1 activity. That is one reason eye-care clinicians are watching whether it behaves differently from brimonidine over long-term use, and why its prescription labels mention upper lid elevation as an effect: alpha-1 stimulation can slightly lift the upper eyelid.

Does Brytly Really Last 50% Longer?

On the label, yes: 12 hours versus 8 hours is 50% longer. Alcon’s press release footnotes that the claim is “based on label claim,” not on a study that put both drops side by side. No head-to-head Brytly vs Lumify trial has been published. Longer duration also does not mean a bigger or faster whitening effect, and individual results vary.

The practical trade-off is dosing. Brytly is capped at 2 uses a day; Lumify can be used up to 4 times. If one drop in the morning and maybe one in the evening covers your day, Brytly’s longer label is convenient. If you tend to re-dose before a meeting, photos or an evening event, Lumify’s schedule is more flexible.

What Do the Clinical Trials Show?

Brytly (apraclonidine 0.125%)

Alcon’s registered phase 3 trial (NCT06444529) enrolled 159 people and compared apraclonidine with its vehicle (the same drop without the drug) for about 8 weeks. Its co-primary endpoints were investigator-graded redness at 15 minutes and at 10 hours after the first dose. Results presented at the American Academy of Optometry meeting in October 2026 (a 125-adult phase 3 study) reported that apraclonidine reduced redness more than vehicle by 1.60 units at 15 minutes and 1.00 unit at 10 hours on a 0–4 scale, with significant reductions from 1 minute through 12 hours. Reductions held at days 14, 28 and 56, with no sign of tachyphylaxis; rebound redness after stopping was low in both groups, and adverse events were infrequent and mostly mild. These results had not yet appeared in a peer-reviewed journal as of October 2026, and the rebound and tachyphylaxis claims in Alcon’s release cite internal “data on file.”

Lumify (brimonidine 0.025%)

Lumify’s pivotal phase 3 trial (McLaurin 2018, Optometry and Vision Science) randomized 60 adults to brimonidine or vehicle four times a day for 4 weeks. Redness dropped within 1 minute and stayed lower for up to 8 hours, and the effect was similar on days 15 and 29, meaning no tachyphylaxis. Investigators saw rebound redness in 1 of 40 brimonidine users after stopping. A 2025 multicenter trial (Ophthalmology and Therapy) found the preservative-free formulation was non-inferior to original Lumify over 4 weeks, with similarly low rebound rates and no serious eye events.

Side Effects and Safety

• Both: For external use only. Stop and ask a doctor if you have eye pain, vision changes, continued redness or irritation, or if redness lasts more than 3 days or gets worse (Drug Facts for Lumify; FDA statement for Brytly). Wait 5 minutes between different eye drops.
• Allergy history with apraclonidine: In long-term use of prescription apraclonidine 0.5%, allergic-like eye reactions were reported in 12.9% of patients, and 15% stopped treatment because of side effects such as redness, itching and tearing. Those rates come from a 4-times-stronger glaucoma drop used up to three times daily, so they cannot be applied directly to Brytly, but anyone who has reacted to Iopidine, apraclonidine or clonidine should ask a pharmacist before trying Brytly.
• Drug interactions: Prescription apraclonidine is contraindicated in people taking monoamine oxidase inhibitor (MAOI) antidepressants, and prescription brimonidine labels also list MAOIs as a possible interaction. If you take an MAOI, other antidepressants, or blood pressure medicines, check with a pharmacist before using either OTC drop.
• Preservatives: Benzalkonium chloride (BAK) keeps multi-dose bottles sterile but can irritate sensitive or dry eyes with frequent use. Lumify offers a preservative-free bottle; confirm the ingredients on any Brytly carton.
• Pregnancy and breastfeeding: Lumify’s label says to ask a health professional before use. Do the same for Brytly.
• Children: Lumify is labeled from age 5; Brytly only from age 12. Keep both out of reach of children; if swallowed, call Poison Control (1-800-222-1222).

Who Should Choose What

• Choose Brytly if: you are 12 or older, want a single drop that may last through a full workday or event, and rarely need more than two doses a day.
• Choose Lumify if: you are buying for a child aged 5–11, want the option to re-dose up to 4 times a day, prefer a product with years of published rebound data, or need a preservative-free bottle.
• Choose neither (use artificial tears) if: your eyes feel dry, gritty or tired. Lubricating drops treat the cause of a lot of redness. See our Visine vs Systane and dry eye treatment guide.
• See an eye doctor instead if: one eye is very red or painful, you have discharge, light sensitivity or blurred vision, you wear contacts and your eye is red and sore, or you have needed a whitening drop most days for weeks.

Can You Use Brytly or Lumify Every Day?

Both are labeled for redness due to minor eye irritations, and both tell you to stop and see a doctor if redness lasts more than 3 days. The trials ran for 4 weeks (Lumify) and about 8 weeks (Brytly), so data beyond two months of continuous use are limited. Needing a whitening drop every day is a signal to look for the cause, such as dry eye, allergies, blepharitis, contact lens overwear or screen strain (see our eye strain relief guide), rather than to mask it.

The Bottom Line

When to Talk to Your Doctor or Pharmacist

Ask a pharmacist before using either drop if you have glaucoma or take eye-pressure medicines, take MAOIs or other antidepressants, have heart disease or low blood pressure, are pregnant or breastfeeding, or have had a reaction to clonidine, apraclonidine or brimonidine. See an eye doctor promptly for a painful red eye, sudden vision change, light sensitivity, a red eye after an injury or chemical splash, or a red eye while wearing contact lenses.

Frequently Asked Questions

Sources

• FDA (Oct 16, 2026): FDA approves new nonprescription eye drop for relief of eye redness (Brytly)
• Alcon media release (Oct 16, 2026): FDA approves Alcon’s BRYTLY redness reliever eye drops
• ClinicalTrials.gov NCT06444529: Apraclonidine hydrochloride ophthalmic solution vs vehicle for ocular redness (Alcon)
• Vedamurthy I, Nakagawara E. Clinical efficacy and safety of apraclonidine HCl 0.125% for ocular redness in adults: a phase 3 study. Academy 2026 presentation (summary, Optometry 360)
• DailyMed: Lumify redness reliever eye drops (brimonidine tartrate 0.025%) Drug Facts
• DailyMed: Lumify preservative-free eye drops
• McLaurin E et al. Brimonidine ophthalmic solution 0.025% for reduction of ocular redness: a randomized clinical trial. Optom Vis Sci. 2018
• A multicenter randomized double-masked study comparing preservative-free brimonidine tartrate 0.025% with Lumify 0.025% for ocular redness in adults. Ophthalmol Ther. 2025
• Hosten LO, Snyder C. Over-the-counter ocular decongestants in the United States: mechanisms of action and clinical utility. Clin Optom. 2020
• DailyMed: Apraclonidine ophthalmic solution 0.5% (prescription) prescribing information
• DailyMed: Iopidine (apraclonidine 1%) prescribing information

Related Comparisons

• Visine vs Systane
• Dry Eye Treatment Guide
• Eye Strain Relief Guide
• Zyrtec vs Claritin
• Flonase vs Astepro
• All Medicine Comparisons